Medtech, pharma industry slates Obama's 2014 budget for US FDA
This article was originally published in Clinica
Executive Summary
Medtech and pharma companies in the US have criticized President Barack Obama's $4.7 billion budget proposal for the Food and Drug Administration for fiscal year 2014, saying several of its provisions are "bad for patients, bad for innovation, and bad for the economy".